Diabetes, Obesity and Erectile Dysfunction: Field Overview and Research Priorities

Journal of Urology

Volumn 182, Issue 6 SUPPL., 2009, Pages

  Chitaley, Kanchan ^a   Kupelian, Varant ^a   Subak, Leslee ^a   Wessells, Hunter ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

diabetes; epidemiology; impotence; obesity; penis

Indexed keywords

ARTICLE; AUTONOMIC NEUROPATHY; BODY MASS; CARBOHYDRATE METABOLISM; DIABETES MELLITUS; DISEASE MARKER; ERECTILE DYSFUNCTION; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE MODIFICATION; MOLECULAR BIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESEARCH PRIORITY; RISK FACTOR; SMOOTH MUSCLE CONTRACTILITY;

ANIMALS; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; ERECTILE DYSFUNCTION; HUMANS; LIFE STYLE; MALE; OBESITY; PHENOTYPE; PREVALENCE; RISK FACTORS; RODENTIA;

EID: 72149133951     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.089     Document Type: Article

References (47)

1. Hogan P., Dall T., and Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 26 (2003) 917
2. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549
3. Saigal C.S., Wessells H., Pace J., et al. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 166 (2006) 207
4. Brown J.S., Wessells H., Chancellor M.B., et al. Urologic complications of diabetes. Diabetes Care 28 (2005) 177
5. Chitaley K: Type 1 and type 2 diabetic-erectile dysfunction: same diagnosis (ICD-9), different disease? J Sex Med, suppl., 1009; 6: 262.
6. Bacon C.G., Hu F.B., Giovannucci E., et al. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 25 (2002) 1458
7. Johannes C.B., Araujo A.B., Feldman H.A., et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol 163 (2000) 460
8. Fedele D., Coscelli C., Santeusanio F., et al. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care 21 (1998) 1973
9. Klein R., Klein B.E., and Moss S.E. Ten-year incidence of self-reported erectile dysfunction in people with long-term type 1 diabetes. J Diabetes Compl 19 (2005) 35
10. Thompson I.M., Tangen C.M., Goodman P.J., et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA 294 (2005) 2996
11. Ma R.C., So W.Y., Yang X., et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol 51 (2008) 2045
12. Kupelian V., Shabsigh R., Araujo A.B., et al. Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study. J Urol 176 (2006) 222
13. Araujo A.B., Travison T.G., Ganz P.A., et al. Erectile dysfunction as a predictor of coronary heart disease in aging men: prospective results from the Massachusetts Male Aging Study. J Urol 175 suppl. (2006) 427 abstract 1326
14. Corona G., Mannucci E., Petrone L., et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res 18 (2006) 190
15. El-Sakka A.I., Sayed H.M., and Tayeb K.A. Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction. Int J Androl 31 (2008) 602
16. Corona G., Mannucci E., Petrone L., et al. NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med 4 (2007) 1038
17. Kapoor D., Clarke S., Channer K.S., et al. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. Int J Androl 30 (2007) 500
18. Goldstein I., Young J.M., Fischer J., et al. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 26 (2003) 777
19. Rendell M.S., Rajfer J., Wicker P.A., et al. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 281 (1999) 421
20. Vardi M., and Nini A. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus. Cochrane Database Syst Rev 1 (2007) CD002187
21. Wessells H., Penson D.F., Cleary P., et al. Prevalence and predictors of sexual dysfunction in men with type 1 diabetes enrolled in DCCT/EDIC (June 10-14, 2005) Presented at annual meeting of American Diabetes Association, San Diego, California
22. Khatana S.A., Taveira T.H., Miner M.M., et al. Does cardiovascular risk reduction alleviate erectile dysfunction in men with type II diabetes mellitus?. Int J Impot Res 20 (2008) 501
23. Kolotkin R.L., Binks M., Crosby R.D., et al. Obesity and sexual quality of life. Obes (Silver Spring) 14 (2006) 472
24. Esposito K., Giugliano F., Di Palo C., et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291 (2004) 2978
25. Dallal R.M., Chernoff A., O'Leary M.P., et al. Sexual dysfunction is common in the morbidly obese male and improves after gastric bypass surgery. J Am Coll Surg 207 (2008) 859
26. Kaukua J., Pekkarinen T., Sane T., et al. Health-related quality of life in obese outpatients losing weight with very-low-energy diet and behaviour modification-a 2-y follow-up study. Int J Obes Relat Metab Disord 27 (2003) 1233
27. Eaton C.B., Liu Y.L., Mittleman M.A., et al. A retrospective study of the relationship between biomarkers of atherosclerosis and erectile dysfunction in 988 men. Int J Impot Res 19 (2007) 218
28. Bocchio M., Desideri G., Scarpelli P., et al. Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol 171 (2004) 1601
29. Esposito K., Ciotola M., Giugliano F., et al. Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction. J Sex Med 5 (2008) 1436
30. Morano S., Mandosi E., Fallarino M., et al. Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. Eur Urol 52 (2007) 1768
31. Morano S., Gatti A., Mandosi E., et al. Circulating monocyte oxidative activity is increased in patients with type 2 diabetes and erectile dysfunction. J Urol 177 (2007) 655
32. Burnett A.L., Strong T.D., Trock B.J., et al. Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction. J Urol 181 (2009) 245
33. National Diabetes Fact Sheet (2007), Centers for Disease Control and Prevention, Bethesda
34. Kasiske B.L., O'Donnell M.P., and Keane W.F. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 19 suppl. (1992) I110
35. Guberski D.L., Butler L., Manzi S.M., et al. The BBZ/Wor rat: clinical characteristics of the diabetic syndrome. Diabetologia 36 (1993) 912
36. Vernet D., Cai L., Garban H., et al. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 136 (1995) 5709
37. Kawano K., Hirashima T., Mori S., et al. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41 (1992) 1422
38. Surwit R.S., Kuhn C.M., Cochrane C., et al. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163
39. Xie D., Odronic S.I., Wu F., et al. Mouse model of erectile dysfunction due to diet-induced diabetes mellitus. Urology 70 (2007) 196
40. Sharma K., McCue P., and Dunn S.R. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284 (2003) F1138
41. Carneiro F.S., Zemse S., Giachini F.R., et al. TNF-alpha infusion impairs corpora cavernosa reactivity. J Sex Med 6 suppl. (2009) 311
42. Hidalgo-Tamola J., and Chitaley K. Review type 2 diabetes mellitus and erectile dysfunction. J Sex Med 6 (2009) 916
43. Disanto M.E. Contractile mechanisms in diabetes-related erectile dysfunction. Curr Pharm Des 11 (2005) 3995
44. Luttrell I.P., Swee M., Starcher B., et al. Erectile dysfunction in the type II diabetic db/db mouse: impaired venoocclusion with altered cavernosal vasoreactivity and matrix. Am J Physiol Heart Circ Physiol 294 (2008) H2204
45. Carneiro F.S., Giachini F.R., Lima V.V., et al. Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse. J Sex Med 5 (2008) 1156
46. Wingard C., Fulton D., and Husain S. Altered penile vascular reactivity and erection in the Zucker obese-diabetic rat. J Sex Med 4 (2007) 348
47. Kovanecz I., Ferrini M.G., Vernet D., et al. Pioglitazone prevents corporal veno-occlusive dysfunction in a rat model of type 2 diabetes mellitus. BJU Int 98 (2006) 116